These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3246395)

  • 1. Prevalence of hepatitis-B virus markers in multi-transfused thalassemic patients.
    Mital MK; Vij JC; Talukdar B; Sachdev HP; Saini L
    Indian Pediatr; 1988 Feb; 25(2):161-5. PubMed ID: 3246395
    [No Abstract]   [Full Text] [Related]  

  • 2. Serological responses to hepatitis B virus infection in multi-transfused thalassemic children.
    Gulati S; Marwaha RK; Dilawari JB; Midha U; Walia BN
    Indian Pediatr; 1992 Jan; 29(1):73-7. PubMed ID: 1601501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of hepatitis B vaccine in multi-transfused thalassemic patients with and without hepatitis C infection: a comparative study with healthy controls.
    Froutan-Pishbijari H; Ghofrani H; Mirmomenm S; Kazemi-Asl S; Nassiri-Toosi M; Farahvash MJ; Toroghi HH; Aminian K; Mansour-Ghanaei F; Bagherzadeh AH
    Med Sci Monit; 2004 Dec; 10(12):CR679-83. PubMed ID: 15567986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Incidence of Australia antigen (HB Ag) and its related antibody (HB Ab) in Siciliam thalassemic children treated with multiple transfusions].
    Musumeci S; Di Gregorio F; Marino S; Fischer A; Pizzarelli G
    Pediatria (Napoli); 1977 Mar; 85(1):21-33. PubMed ID: 876745
    [No Abstract]   [Full Text] [Related]  

  • 5. [Circulation of the markers of the hepatitis B virus in different clinical forms of the disease].
    Frolov AF; Raksha EA; Nagornova TF; Vasilenko LG
    Vrach Delo; 1984 Apr; (4):108-11. PubMed ID: 6741040
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis B markers among dialysis patients without hepatitis B surface antigen or antibody.
    Kelly TJ; Sanchez TV; Patterson MJ; Mayor GH
    Proc Clin Dial Transplant Forum; 1980; 10():165-8. PubMed ID: 7346842
    [No Abstract]   [Full Text] [Related]  

  • 7. [Application of time-resolved fluoroimmunoassay in the detection of HBV markers].
    Luo KZ; Yang X; Su XS; Xu Y; Li LY
    Zhonghua Gan Zang Bing Za Zhi; 2003 Sep; 11(9):569. PubMed ID: 14552731
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence of hepatitis B markers in Indochinese refugees.
    Chaudhary RK; Nicholls ES; Kennedy DA
    Can Med Assoc J; 1981 Dec; 125(11):1243-6. PubMed ID: 7332883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serological markers correlated with hepatitis B virus. Study made predominantly in chronic hepatitis in children].
    Calzia R; Ciravegna B; Navone C; Fiorini R; Tolentino P
    Minerva Pediatr; 1981 Aug; 33(16):805-15. PubMed ID: 6273707
    [No Abstract]   [Full Text] [Related]  

  • 10. [Seroepidemiology of hepatitis B in pediatric age. Studies conducted in the city of Rome].
    Mastroeni I; Vescia N; Pompa MG; Signorelli C
    Ann Ig; 1990; 2(1-2):15-9. PubMed ID: 1711334
    [No Abstract]   [Full Text] [Related]  

  • 11. [Favorable outcome in chronic active hepatitis caused by B virus in childhood].
    Cadrobbi P; Bortolotti F; Crivellaro C; Rugge M; Armigliato M; Realdi G; Bertaggia A
    Minerva Pediatr; 1984 Jul; 36(13-14):685-9. PubMed ID: 6503897
    [No Abstract]   [Full Text] [Related]  

  • 12. Viral markers of hepatitis.
    Velasco M
    Lab Res Methods Biol Med; 1983; 7():103-17. PubMed ID: 6413796
    [No Abstract]   [Full Text] [Related]  

  • 13. Australia antigen (HBsAg) in thallassemia children receiving multiple transfusions.
    Mehta KP; Patil HL; Merchant SM; Babar ST; Baxi AJ; Bapat JP
    Indian Pediatr; 1977 Jun; 14(6):455-9. PubMed ID: 604273
    [No Abstract]   [Full Text] [Related]  

  • 14. Transfusion associated hepatitis C in multi-transfused thalassemic children.
    Mishra D; Pensi T
    Indian Pediatr; 2004 Mar; 41(3):287-8. PubMed ID: 15064522
    [No Abstract]   [Full Text] [Related]  

  • 15. HBsAg seropositivity among multi-transfused thalassemic children.
    Khakhkhar V; Joshi PJ
    Indian J Pathol Microbiol; 2006 Oct; 49(4):516-8. PubMed ID: 17183840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatitis B markers in children with oncological diseases].
    Mikhaĭlov MI; Papernova NIu; Zinov'eva LI; Durnov LA; Makhonova LA
    Vopr Onkol; 1986; 32(1):70-4. PubMed ID: 3946089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The importance of IgM anti-HAV test in hepatitis evaluation (author's transl)].
    Iosa G; Turci F; Cipolloni AP; Cenciotti L
    Quad Sclavo Diagn; 1981 Sep; 17(3):289-93. PubMed ID: 7343983
    [No Abstract]   [Full Text] [Related]  

  • 18. [Identification of the e-system and subtypes in 607 cases of HBsAg carriers].
    Kang RY
    Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Dec; 4(6):329-30. PubMed ID: 6675854
    [No Abstract]   [Full Text] [Related]  

  • 19. [Radioimmunoassay of E antigen and anti-E antibody system of hepatitis B virus].
    Novak I; Kselikova M; Urbankova I
    Probl Gematol Pereliv Krovi; 1982 Mar; 27(3):55-7. PubMed ID: 7088919
    [No Abstract]   [Full Text] [Related]  

  • 20. [Risk of posttransfusion hepatitis in hemophilia patients].
    Margolina AN; Somova AV; Golosova TV; Pliushch OP; Andreev IuN
    Probl Gematol Pereliv Krovi; 1980 Mar; 25(3):46-8. PubMed ID: 7367412
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.